Hiruma, S., Shigiyama, F., Hisatake, S., Mizumura, S., Shiraga, N., Hori, M., . . . Kumashiro, N. (2021). A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: The ASSET study. Cardiovasc Diabetol.
Citação norma ChicagoHiruma, Shigenori, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, and Naoki Kumashiro. "A Prospective Randomized Study Comparing Effects of Empagliflozin to Sitagliptin On Cardiac Fat Accumulation, Cardiac Function, and Cardiac Metabolism in Patients With Early-stage Type 2 Diabetes: The ASSET Study." Cardiovasc Diabetol 2021.
Citação norma MLAHiruma, Shigenori, et al. "A Prospective Randomized Study Comparing Effects of Empagliflozin to Sitagliptin On Cardiac Fat Accumulation, Cardiac Function, and Cardiac Metabolism in Patients With Early-stage Type 2 Diabetes: The ASSET Study." Cardiovasc Diabetol 2021.